Pathophysiology of Bisphosphonates associated Osteonecrosis of the Jaw (R03) | Apply Online

Opportunity Summary:

The NIH funding opportunity PA-06-502, titled "Pathophysiology of Bisphosphonates associated Osteonecrosis of the Jaw (R03)," supports small, focused research projects aimed at understanding why osteonecrosis of the jaw (ONJ) can occur in people exposed to bisphosphonates. The program is jointly sponsored by the National Institute of Dental and Craniofacial Research (NIDCR) and the National Cancer Institute (NCI), reflecting ONJ's relevance to both oral health and cancer care, since bisphosphonates are commonly used to manage bone metastases and other conditions affecting skeletal integrity. The central goal is to fund basic and translational studies that identify and characterize the underlying pathophysiological mechanisms that disrupt oral bone healing and lead to ONJ, with an emphasis on mechanisms rather than purely descriptive observations.

This announcement uses the NIH Small Research Grant (R03) mechanism, which is designed for pilot and developmental work. The intent is to help investigators, particularly those early in building an independent research program, generate initial data and proof-of-concept findings that could support a later, larger application such as an R01. The R03 under this opportunity is not renewable, reinforcing its role as a short, early-stage award rather than long-term support. The scientific scope is coordinated with two parallel announcements with the same research focus but different mechanisms: an R01 option (PA-06-500) for full-scale projects and an R21 option (PA-06-501) for exploratory/developmental studies.

A key feature of this FOA is how narrowly it defines what counts as responsive science. Projects must focus on oral bone homeostasis and the oral bone healing/repair response in the presence or absence of bisphosphonates, rather than investigating broad systemic effects of these drugs on general bone quality. Studies that examine skeletal biology in general are considered out of scope unless they directly include analysis of oral bones, which is the core tissue of concern in ONJ. The FOA also allows work on related biological processes, such as angiogenesis, but only when those processes are explicitly tied to how oral bone homeostasis and wound healing might be compromised in a way that contributes to ONJ. In other words, the relevance has to be mechanistic and jaw-specific, not just a general interest in bisphosphonate biology.

The announcement also draws clear boundaries around topics it will not support. Epidemiological studies are described as non-responsive, meaning the FOA is not intended for population-level incidence, risk-factor association, or surveillance work. Straight pharmacology projects are also non-responsive unless they specifically test whether genetic variation changes bisphosphonate pharmacokinetics or pharmacodynamics, which would connect drug exposure and biological response to potential susceptibility mechanisms. This highlights the program's preference for mechanistic, hypothesis-driven work that can explain impaired healing and necrosis in jaw bone, rather than studies that only characterize drug behavior or clinical patterns without digging into causal pathways.

In terms of funding and administrative details, the opportunity is categorized as a discretionary grant with no cost sharing or matching requirement, and it lists an award ceiling of $50,000. It falls under CFDA numbers 93.121 (Oral Diseases and Disorders Research) and 93.395 (Cancer Treatment Research), consistent with the co-lead institutes. The posting date is July 31, 2006, with multiple receipt dates indicated; the current closing date noted in the source summary is September 7, 2009, and the archive date is October 7, 2009. The eligible applicant pool is broad and includes public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status), for-profit organizations other than small businesses, small businesses, local and state governmental entities, tribal governments and organizations, public housing authorities, and other applicants as allowed by NIH policy. Foreign institutions are explicitly eligible, as are eligible federal agencies, and faith-based or community-based organizations. Applicants may submit more than one application as long as each submission is scientifically distinct, which can be helpful for investigators exploring multiple mechanistic angles on ONJ.

Overall, this FOA is best understood as a targeted, jaw-specific mechanistic research call meant to accelerate early-stage studies on how bisphosphonate exposure can derail oral bone healing and set the stage for osteonecrosis. Successful applications under this R03 would typically propose tightly scoped experiments that directly interrogate plausible biological pathways affecting jaw bone repair capacity and tissue viability, generating the kind of preliminary data needed to compete for larger NIH awards focused on ONJ prevention, risk stratification, or therapeutic intervention.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Pathophysiology of Bisphosphonates associated Osteonecrosis of the Jaw (R21)

Previous opportunity: Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis(R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 06 502

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 06 502) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 06 502", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.